NHS National Generic Pharmaceuticals Wave 13

A Contract Award Notice
by ATAMIS LTD

Source
Contracts Finder
Type
Framework (Products)
Duration
28 month
Value
£470M
Sector
HEALTH
Published
20 Jan 2022
Delivery
01 Feb 2022 to 31 May 2024
Deadline
26 Jul 2021 13:00

Concepts

Location

Geochart for 1 buyers and 132 suppliers

1 buyer

132 suppliers

Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

Award Detail

1 Pfizer (None)
  • Value: £469,741,550
2 Merck Sharpe & Dohme (London)
  • Value: £469,741,550
3 Allergan (Marlow)
  • Value: £469,741,550
4 Medreich (Weybridge)
  • Value: £469,741,550
5 Ennogen Healthcare (Dartford)
  • Value: £469,741,550
6 Glaxosmithkline (London)
  • Value: £469,741,550
7 Syri (Ruislip)
  • Value: £469,741,550
8 Hameln Pharma (Gloucester)
  • Value: £469,741,550
9 Medac Pharma (Stirling)
  • Value: £469,741,550
10 Martindale Pharma (Romford)
  • Value: £469,741,550
11 Rosemont Pharmaceuticals (Leeds)
  • Value: £469,741,550
12 Mercury Pharmaceuticals (London)
  • Value: £469,741,550
13 Selective Supplies (London)
  • Value: £469,741,550
14 Nexcape Pharmaceuticals (London)
  • Value: £469,741,550
15 Consilient Health (Richmond upon Thames)
  • Value: £469,741,550
16 Sandoz (Camberley)
  • Value: £469,741,550
17 Fresenius Kabi (Runcorn)
  • Value: £469,741,550
18 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £469,741,550
19 Laboratorio Reig Jofre (Bideford)
  • Value: £469,741,550
20 Kent Pharma (Heathrow)
  • Value: £469,741,550
21 Bowmed Ibisqus (Manchester)
  • Value: £469,741,550
22 Kensington Pharma (Preston)
  • Value: £469,741,550
23 Healthcare Pharma (Haslemere)
  • Value: £469,741,550
24 Thornton & Ross (Huddersfield)
  • Value: £469,741,550
25 Mylan (Potters Bar)
  • Value: £469,741,550
26 Macleods Pharma (Billingham)
  • Value: £469,741,550
27 Wockhardt (Wrexham)
  • Value: £469,741,550
28 Thea Pharmaceuticals (Keele)
  • Value: £469,741,550
29 DR Falk Pharma (Bourne End)
  • Value: £469,741,550
30 Desitin Pharma (Woking)
  • Value: £469,741,550
31 Stragen (Horsham)
  • Value: £469,741,550
32 B Braun Medical (Sheffield)
  • Value: £469,741,550
33 Torrent Pharma (Crawley)
  • Value: £469,741,550
34 Fontus Health (Walsall)
  • Value: £469,741,550
35 Aspire Pharma (Godalming)
  • Value: £469,741,550
36 Teva (Castleford)
  • Value: £469,741,550
37 Amarox (Harrow)
  • Value: £469,741,550
38 Aop Orphan (Weybridge)
  • Value: £469,741,550
39 Pierre Fabre (London)
  • Value: £469,741,550
40 Macure Pharma Aps (Copenhagen)
  • Value: £469,741,550
41 Ranbaxy (Hayes)
  • Value: £469,741,550
42 Arcadia Pharma (Fforestfach)
  • Value: £469,741,550
43 Derma (Ouseburn)
  • Value: £469,741,550
44 Zista Pharma (Stevenage)
  • Value: £469,741,550
45 Drreddys Laboratories (Beverley)
  • Value: £469,741,550
46 Aspen Pharmacare (Maidenhead)
  • Value: £469,741,550
47 Manx Healthcare (Warwick)
  • Value: £469,741,550
48 Colonis Pharma (London)
  • Value: £469,741,550
49 Roche Products (Welwyn Garden City)
  • Value: £469,741,550
50 Waverley Pharma Europe (None)
  • Value: £469,741,550
51 Profile Pharma (Chichester)
  • Value: £469,741,550
52 Reckitt Benckiser (Slough)
  • Value: £469,741,550
53 Zentiva Pharma (London)
  • Value: £469,741,550
54 Baxter Healthcare (Thetford)
  • Value: £469,741,550
55 Organon Pharmaceuticals (London)
  • Value: £469,741,550
56 Day Lewis Medical (Croydon)
  • Value: £469,741,550
57 Logixx Pharma (Reading)
  • Value: £469,741,550
58 Lundbeck (Watford)
  • Value: £469,741,550
59 Napp Pharmaceuticals (Cambridge)
  • Value: £469,741,550
60 Bayer (Reading)
  • Value: £469,741,550
61 Recordati Rare Diseases (Maidenhead)
  • Value: £469,741,550
62 Morningside Pharmaeuticals (Northampton)
  • Value: £469,741,550
63 Dexcel Pharma (Daventry)
  • Value: £469,741,550
64 CST Pharma (Walsall)
  • Value: £469,741,550
65 Cipla Eu (Addlestone)
  • Value: £469,741,550
66 Flexipharm Austrading (Bourne End)
  • Value: £469,741,550
67 Relonchem (Widnes)
  • Value: £469,741,550
68 Leo Pharma (Hurley)
  • Value: £469,741,550
69 Aguettant (Bristol)
  • Value: £469,741,550
70 Torbay Pharmaceuticals (Paignton)
  • Value: £469,741,550
71 RPH Pharmaceuticals (Cheadle)
  • Value: £469,741,550
72 Drugsrus (Northwood)
  • Value: £469,741,550
73 Ferring Pharmaceuticals (West Drayton)
  • Value: £469,741,550
74 Milpharm (South Ruislip)
  • Value: £469,741,550
75 Pari (London)
  • Value: £469,741,550
76 Crescent Pharma (Basingstoke)
  • Value: £469,741,550
77 Roma Pharmaceuticals (Burton upon Trent)
  • Value: £469,741,550
78 Kyowa Kirin (Galashiels)
  • Value: £469,741,550
79 Brown & Burk (Hounslow)
  • Value: £469,741,550
80 Seacross Pharmaceuticals (London)
  • Value: £469,741,550
81 Lupin Healthcare (Slough)
  • Value: £469,741,550
82 Alliance Pharmaceuticals (Chippenham)
  • Value: £469,741,550
83 Bristol Laboratories (Berkhamsted)
  • Value: £469,741,550
84 Aristo Pharma (Ely)
  • Value: £469,741,550
85 Synchrony (Stevenage)
  • Value: £469,741,550
86 Alissa Healthcare Research (Fareham)
  • Value: £469,741,550
87 Altan Pharma (None)
  • Value: £469,741,550
88 Lucane Pharma (Ankeveen)
  • Value: £469,741,550
89 Norgine Pharmaceuticals (Uxbridge)
  • Value: £469,741,550
90 Neon Healthcare (Hertford)
  • Value: £469,741,550
91 Aventis Pharma (Reading)
  • Value: £469,741,550
92 Mip Pharma (Blieskastel Niederwuerzbach)
  • Value: £469,741,550
93 Accord (Barnstaple)
  • Value: £469,741,550
94 Acium (Stevenage)
  • Value: £469,741,550
95 Ascend Laboratories (London)
  • Value: £469,741,550
96 Rivopharm (London)
  • Value: £469,741,550
97 Strides Pharma (Watford)
  • Value: £469,741,550
98 V Pharma (None)
  • Value: £469,741,550
99 Atnahs Pharma (London)
  • Value: £469,741,550
100 Chiesi (Manchester)
  • Value: £469,741,550
101 Correvio (Bielefeld)
  • Value: £469,741,550
102 Flynn Pharma (Stevenage)
  • Value: £469,741,550
103 Focus Pharmaceuticals (London)
  • Value: £469,741,550
104 Galen (Portadown)
  • Value: £469,741,550
105 Recordati Pharmaceuticals (Bracknell)
  • Value: £469,741,550
106 Takeda (None)
  • Value: £469,741,550
107 Tillomed Laboratories (Luton)
  • Value: £469,741,550
108 Upjohn (Sandwich)
  • Value: £469,741,550
109 Waymade (London)
  • Value: £469,741,550
110 Alturix (Milton Keynes)
  • Value: £469,741,550
111 Beaumont Pharma (Burnley)
  • Value: £469,741,550
112 Clydesdale Pharma (Tadley)
  • Value: £469,741,550
113 Euro Link Pharma (Luton)
  • Value: £469,741,550
114 Ferndale Pharmaceuticals (Thorp Arch Estate)
  • Value: £469,741,550
115 Intrapharm Laboratories (Maidenhead)
  • Value: £469,741,550
116 Ipca Laboratories (Tyne and Wear)
  • Value: £469,741,550
117 Medley Pharma (Merseyside)
  • Value: £469,741,550
118 Mibe Pharma (London)
  • Value: £469,741,550
119 Necessity Supplies (Northolt)
  • Value: £469,741,550
120 Northumbria Pharma (Sedgefield)
  • Value: £469,741,550
121 Noumed Life Sciences (Maidenhead)
  • Value: £469,741,550
122 Oralieve (Luton)
  • Value: £469,741,550
123 PM Pharma (Norwich)
  • Value: £469,741,550
124 Panpharma (Merseyside)
  • Value: £469,741,550
125 Phoenix Lab (None)
  • Value: £469,741,550
126 Sciecure Pharma (Guildford)
  • Value: £469,741,550
127 Sintetica (London)
  • Value: £469,741,550
128 Sobi Swedish Orphan Biovitrum (Great Abington)
  • Value: £469,741,550
129 Tetris Pharma (Northampton)
  • Value: £469,741,550
130 Transdermal (None)
  • Value: £469,741,550
131 Typharm (None)
  • Value: £469,741,550
132 Vantage Pharmaceuticals (Hemel Hempstead)
  • Value: £469,741,550

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Reference

Domains